Bulletin
Investor Alert

London Markets Open in:

Jan. 5, 2021, 7:46 p.m. EST

Hemostats Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Baxter International Inc. (BAX)
  • X
    Integra LifeSciences Holdings Corp. (IART)
  • X
    Johnson & Johnson (JNJ)

or Cancel Already have a watchlist? Log In

Jan 05, 2021 (SUPER MARKET RESEARCH via COMTEX) -- According to IMARC Group's latest report, titled "Hemostats Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025," the global hemostats market to continue its moderate growth during the next five years.

Hemostats are the medical devices that compress blood vessels and reduce the flow of blood or other fluids. They are majorly used during surgical procedures to control bleeding in patients. Hemostatic agents enable faster wound healing, reduce operative time, enhance patient's recovery, and help in treating anticoagulated patients. Various surgical hemostatic agents are available based on different compositions, immunogenicity, and the mechanism of action, application and adherence.

Request for a free sample copy of this report: https://www.imarcgroup.com/hemostats-market/requestsample

Market Trends

The growing prevalence of chronic blood-related disorders, cesarean deliveries, fatal injuries, organ surgeries, etc., is primarily driving the demand for hemostats to reduce blood loss. Moreover, several technological advancements have led to the development of absorbable adjunctive hemostats that help in controlling disruptive bleeding more efficiently than the conventional devices. Additionally, the growing utilization of nano- and micro-materials for treating uncontrolled hemorrhage and internal bleeding is also augmenting the market growth. Several manufacturers have introduced advanced laparoscopic hemostats to enhance surgical operations quality and facilitate less invasive procedures, which are further expected to drive the global market.

Hemostats 2020-2025 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Arch Therapeutics Inc. (otcmkts:ARTH)

  • Baxter International Inc. /zigman2/quotes/207334572/composite BAX +0.49%

  • Braun Melsungen Aktiengesell

  • R. Bard Inc.

  • GELITA MEDICAL GmbH

  • Integra LifeSciences Corporation /zigman2/quotes/200866868/composite IART -1.42%

  • Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.10%

  • Pfizer Inc. NYSE: PFE()

  • Stryker Corporation /zigman2/quotes/207664662/composite SYK -1.22%

  • Teleflex Incorporated /zigman2/quotes/209322043/composite TFX +0.52%

  • Z-Medica LLC.

Breakup by Product:

  • Thrombin Based

  • Combination Based

  • Oxidized Regenerated Cellulose Based

  • Gelatin Based

  • Collagen Based

Breakup by Application:

  • Orthopedic Surgery

  • General Surgery

  • Neurological Surgery

  • Cardiovascular Surgery

/zigman2/quotes/207334572/composite
US : U.S.: NYSE
$ 78.65
+0.39 +0.49%
Volume: 2.61M
Feb. 25, 2021 4:00p
P/E Ratio
36.89
Dividend Yield
1.25%
Market Cap
$39.66 billion
Rev. per Employee
$233,460
loading...
/zigman2/quotes/200866868/composite
US : U.S.: Nasdaq
$ 69.24
-1.00 -1.42%
Volume: 512,382
Feb. 25, 2021 4:00p
P/E Ratio
43.93
Dividend Yield
N/A
Market Cap
$5.93 billion
Rev. per Employee
$370,775
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 162.76
+0.17 +0.10%
Volume: 9.72M
Feb. 25, 2021 4:00p
P/E Ratio
29.52
Dividend Yield
2.48%
Market Cap
$427.40 billion
Rev. per Employee
$613,918
loading...
/zigman2/quotes/207664662/composite
US : U.S.: NYSE
$ 245.78
-3.04 -1.22%
Volume: 958,091
Feb. 25, 2021 4:05p
P/E Ratio
58.51
Dividend Yield
1.03%
Market Cap
$93.61 billion
Rev. per Employee
$333,744
loading...
/zigman2/quotes/209322043/composite
US : U.S.: NYSE
$ 402.48
+2.09 +0.52%
Volume: 252,363
Feb. 25, 2021 4:04p
P/E Ratio
51.76
Dividend Yield
0.34%
Market Cap
$18.64 billion
Rev. per Employee
$180,233
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.